Summary

The global Estrogen and Progesterone market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Progesterone and estrogen are the two most important hormones in the female body. These are steroid hormones that are responsible for various female characteristics in the body.
United States market for Estrogen and Progesterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Estrogen and Progesterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Estrogen and Progesterone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Estrogen and Progesterone players cover Gedeon Richter, Bayer, N.V.Organon, Pfizer Healthcare, Jenapharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Estrogen and Progesterone Industry Forecast” looks at past sales and reviews total world Estrogen and Progesterone sales in 2024, providing a comprehensive analysis by region and market sector of projected Estrogen and Progesterone sales for 2025 through 2031. With Estrogen and Progesterone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Estrogen and Progesterone industry.
This Insight Report provides a comprehensive analysis of the global Estrogen and Progesterone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Estrogen and Progesterone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Estrogen and Progesterone market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Estrogen and Progesterone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Estrogen and Progesterone.
This report presents a comprehensive overview, market shares, and growth opportunities of Estrogen and Progesterone market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Estrogen
Progesterone
Segmentation by Application:
Pharmacy
Hospital
Department of Endocrinology
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Gedeon Richter
Bayer
N.V.Organon
Pfizer Healthcare
Jenapharm
Besins Healthcare
MERCK SERONO
Abbott
Teva Pharma
Aspen Pharmacare
Dr.Kade Pharmazeutische Fabrik
F.I.S.-FABBRICA
Eli Lilly
Orion
AstraZeneca
Novartis Pharma
Novo Nordisk
Key Questions Addressed in this Report
What is the 10-year outlook for the global Estrogen and Progesterone market?
What factors are driving Estrogen and Progesterone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Estrogen and Progesterone market opportunities vary by end market size?
How does Estrogen and Progesterone break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Estrogen and Progesterone Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Estrogen and Progesterone by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Estrogen and Progesterone by Country/Region, 2020, 2024 & 2031
2.2 Estrogen and Progesterone Segment by Type
2.2.1 Estrogen
2.2.2 Progesterone
2.3 Estrogen and Progesterone Sales by Type
2.3.1 Global Estrogen and Progesterone Sales Market Share by Type (2020-2025)
2.3.2 Global Estrogen and Progesterone Revenue and Market Share by Type (2020-2025)
2.3.3 Global Estrogen and Progesterone Sale Price by Type (2020-2025)
2.4 Estrogen and Progesterone Segment by Application
2.4.1 Pharmacy
2.4.2 Hospital
2.4.3 Department of Endocrinology
2.5 Estrogen and Progesterone Sales by Application
2.5.1 Global Estrogen and Progesterone Sale Market Share by Application (2020-2025)
2.5.2 Global Estrogen and Progesterone Revenue and Market Share by Application (2020-2025)
2.5.3 Global Estrogen and Progesterone Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Estrogen and Progesterone Breakdown Data by Company
3.1.1 Global Estrogen and Progesterone Annual Sales by Company (2020-2025)
3.1.2 Global Estrogen and Progesterone Sales Market Share by Company (2020-2025)
3.2 Global Estrogen and Progesterone Annual Revenue by Company (2020-2025)
3.2.1 Global Estrogen and Progesterone Revenue by Company (2020-2025)
3.2.2 Global Estrogen and Progesterone Revenue Market Share by Company (2020-2025)
3.3 Global Estrogen and Progesterone Sale Price by Company
3.4 Key Manufacturers Estrogen and Progesterone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Estrogen and Progesterone Product Location Distribution
3.4.2 Players Estrogen and Progesterone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Estrogen and Progesterone by Geographic Region
4.1 World Historic Estrogen and Progesterone Market Size by Geographic Region (2020-2025)
4.1.1 Global Estrogen and Progesterone Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Estrogen and Progesterone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Estrogen and Progesterone Market Size by Country/Region (2020-2025)
4.2.1 Global Estrogen and Progesterone Annual Sales by Country/Region (2020-2025)
4.2.2 Global Estrogen and Progesterone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Estrogen and Progesterone Sales Growth
4.4 APAC Estrogen and Progesterone Sales Growth
4.5 Europe Estrogen and Progesterone Sales Growth
4.6 Middle East & Africa Estrogen and Progesterone Sales Growth
5 Americas
5.1 Americas Estrogen and Progesterone Sales by Country
5.1.1 Americas Estrogen and Progesterone Sales by Country (2020-2025)
5.1.2 Americas Estrogen and Progesterone Revenue by Country (2020-2025)
5.2 Americas Estrogen and Progesterone Sales by Type (2020-2025)
5.3 Americas Estrogen and Progesterone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Estrogen and Progesterone Sales by Region
6.1.1 APAC Estrogen and Progesterone Sales by Region (2020-2025)
6.1.2 APAC Estrogen and Progesterone Revenue by Region (2020-2025)
6.2 APAC Estrogen and Progesterone Sales by Type (2020-2025)
6.3 APAC Estrogen and Progesterone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Estrogen and Progesterone by Country
7.1.1 Europe Estrogen and Progesterone Sales by Country (2020-2025)
7.1.2 Europe Estrogen and Progesterone Revenue by Country (2020-2025)
7.2 Europe Estrogen and Progesterone Sales by Type (2020-2025)
7.3 Europe Estrogen and Progesterone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Estrogen and Progesterone by Country
8.1.1 Middle East & Africa Estrogen and Progesterone Sales by Country (2020-2025)
8.1.2 Middle East & Africa Estrogen and Progesterone Revenue by Country (2020-2025)
8.2 Middle East & Africa Estrogen and Progesterone Sales by Type (2020-2025)
8.3 Middle East & Africa Estrogen and Progesterone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Estrogen and Progesterone
10.3 Manufacturing Process Analysis of Estrogen and Progesterone
10.4 Industry Chain Structure of Estrogen and Progesterone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Estrogen and Progesterone Distributors
11.3 Estrogen and Progesterone Customer
12 World Forecast Review for Estrogen and Progesterone by Geographic Region
12.1 Global Estrogen and Progesterone Market Size Forecast by Region
12.1.1 Global Estrogen and Progesterone Forecast by Region (2026-2031)
12.1.2 Global Estrogen and Progesterone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Estrogen and Progesterone Forecast by Type (2026-2031)
12.7 Global Estrogen and Progesterone Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Gedeon Richter
13.1.1 Gedeon Richter Company Information
13.1.2 Gedeon Richter Estrogen and Progesterone Product Portfolios and Specifications
13.1.3 Gedeon Richter Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Gedeon Richter Main Business Overview
13.1.5 Gedeon Richter Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Estrogen and Progesterone Product Portfolios and Specifications
13.2.3 Bayer Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 N.V.Organon
13.3.1 N.V.Organon Company Information
13.3.2 N.V.Organon Estrogen and Progesterone Product Portfolios and Specifications
13.3.3 N.V.Organon Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 N.V.Organon Main Business Overview
13.3.5 N.V.Organon Latest Developments
13.4 Pfizer Healthcare
13.4.1 Pfizer Healthcare Company Information
13.4.2 Pfizer Healthcare Estrogen and Progesterone Product Portfolios and Specifications
13.4.3 Pfizer Healthcare Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Healthcare Main Business Overview
13.4.5 Pfizer Healthcare Latest Developments
13.5 Jenapharm
13.5.1 Jenapharm Company Information
13.5.2 Jenapharm Estrogen and Progesterone Product Portfolios and Specifications
13.5.3 Jenapharm Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Jenapharm Main Business Overview
13.5.5 Jenapharm Latest Developments
13.6 Besins Healthcare
13.6.1 Besins Healthcare Company Information
13.6.2 Besins Healthcare Estrogen and Progesterone Product Portfolios and Specifications
13.6.3 Besins Healthcare Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Besins Healthcare Main Business Overview
13.6.5 Besins Healthcare Latest Developments
13.7 MERCK SERONO
13.7.1 MERCK SERONO Company Information
13.7.2 MERCK SERONO Estrogen and Progesterone Product Portfolios and Specifications
13.7.3 MERCK SERONO Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MERCK SERONO Main Business Overview
13.7.5 MERCK SERONO Latest Developments
13.8 Abbott
13.8.1 Abbott Company Information
13.8.2 Abbott Estrogen and Progesterone Product Portfolios and Specifications
13.8.3 Abbott Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Abbott Main Business Overview
13.8.5 Abbott Latest Developments
13.9 Teva Pharma
13.9.1 Teva Pharma Company Information
13.9.2 Teva Pharma Estrogen and Progesterone Product Portfolios and Specifications
13.9.3 Teva Pharma Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Teva Pharma Main Business Overview
13.9.5 Teva Pharma Latest Developments
13.10 Aspen Pharmacare
13.10.1 Aspen Pharmacare Company Information
13.10.2 Aspen Pharmacare Estrogen and Progesterone Product Portfolios and Specifications
13.10.3 Aspen Pharmacare Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Aspen Pharmacare Main Business Overview
13.10.5 Aspen Pharmacare Latest Developments
13.11 Dr.Kade Pharmazeutische Fabrik
13.11.1 Dr.Kade Pharmazeutische Fabrik Company Information
13.11.2 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolios and Specifications
13.11.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Dr.Kade Pharmazeutische Fabrik Main Business Overview
13.11.5 Dr.Kade Pharmazeutische Fabrik Latest Developments
13.12 F.I.S.-FABBRICA
13.12.1 F.I.S.-FABBRICA Company Information
13.12.2 F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolios and Specifications
13.12.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 F.I.S.-FABBRICA Main Business Overview
13.12.5 F.I.S.-FABBRICA Latest Developments
13.13 Eli Lilly
13.13.1 Eli Lilly Company Information
13.13.2 Eli Lilly Estrogen and Progesterone Product Portfolios and Specifications
13.13.3 Eli Lilly Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Eli Lilly Main Business Overview
13.13.5 Eli Lilly Latest Developments
13.14 Orion
13.14.1 Orion Company Information
13.14.2 Orion Estrogen and Progesterone Product Portfolios and Specifications
13.14.3 Orion Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Orion Main Business Overview
13.14.5 Orion Latest Developments
13.15 AstraZeneca
13.15.1 AstraZeneca Company Information
13.15.2 AstraZeneca Estrogen and Progesterone Product Portfolios and Specifications
13.15.3 AstraZeneca Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 AstraZeneca Main Business Overview
13.15.5 AstraZeneca Latest Developments
13.16 Novartis Pharma
13.16.1 Novartis Pharma Company Information
13.16.2 Novartis Pharma Estrogen and Progesterone Product Portfolios and Specifications
13.16.3 Novartis Pharma Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Novartis Pharma Main Business Overview
13.16.5 Novartis Pharma Latest Developments
13.17 Novo Nordisk
13.17.1 Novo Nordisk Company Information
13.17.2 Novo Nordisk Estrogen and Progesterone Product Portfolios and Specifications
13.17.3 Novo Nordisk Estrogen and Progesterone Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Novo Nordisk Main Business Overview
13.17.5 Novo Nordisk Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Estrogen and Progesterone Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Estrogen and Progesterone Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Estrogen
Table 4. Major Players of Progesterone
Table 5. Global Estrogen and Progesterone Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Estrogen and Progesterone Sales Market Share by Type (2020-2025)
Table 7. Global Estrogen and Progesterone Revenue by Type (2020-2025) & ($ million)
Table 8. Global Estrogen and Progesterone Revenue Market Share by Type (2020-2025)
Table 9. Global Estrogen and Progesterone Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Estrogen and Progesterone Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Estrogen and Progesterone Sale Market Share by Application (2020-2025)
Table 12. Global Estrogen and Progesterone Revenue by Application (2020-2025) & ($ million)
Table 13. Global Estrogen and Progesterone Revenue Market Share by Application (2020-2025)
Table 14. Global Estrogen and Progesterone Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Estrogen and Progesterone Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Estrogen and Progesterone Sales Market Share by Company (2020-2025)
Table 17. Global Estrogen and Progesterone Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Estrogen and Progesterone Revenue Market Share by Company (2020-2025)
Table 19. Global Estrogen and Progesterone Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Estrogen and Progesterone Producing Area Distribution and Sales Area
Table 21. Players Estrogen and Progesterone Products Offered
Table 22. Estrogen and Progesterone Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Estrogen and Progesterone Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Estrogen and Progesterone Sales Market Share Geographic Region (2020-2025)
Table 27. Global Estrogen and Progesterone Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Estrogen and Progesterone Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Estrogen and Progesterone Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Estrogen and Progesterone Sales Market Share by Country/Region (2020-2025)
Table 31. Global Estrogen and Progesterone Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Estrogen and Progesterone Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Estrogen and Progesterone Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Estrogen and Progesterone Sales Market Share by Country (2020-2025)
Table 35. Americas Estrogen and Progesterone Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Estrogen and Progesterone Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Estrogen and Progesterone Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Estrogen and Progesterone Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Estrogen and Progesterone Sales Market Share by Region (2020-2025)
Table 40. APAC Estrogen and Progesterone Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Estrogen and Progesterone Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Estrogen and Progesterone Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Estrogen and Progesterone Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Estrogen and Progesterone Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Estrogen and Progesterone Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Estrogen and Progesterone Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Estrogen and Progesterone Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Estrogen and Progesterone Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Estrogen and Progesterone Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Estrogen and Progesterone Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Estrogen and Progesterone
Table 52. Key Market Challenges & Risks of Estrogen and Progesterone
Table 53. Key Industry Trends of Estrogen and Progesterone
Table 54. Estrogen and Progesterone Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Estrogen and Progesterone Distributors List
Table 57. Estrogen and Progesterone Customer List
Table 58. Global Estrogen and Progesterone Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Estrogen and Progesterone Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Estrogen and Progesterone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Estrogen and Progesterone Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Estrogen and Progesterone Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Estrogen and Progesterone Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Estrogen and Progesterone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Estrogen and Progesterone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Estrogen and Progesterone Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Estrogen and Progesterone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Estrogen and Progesterone Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Estrogen and Progesterone Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Estrogen and Progesterone Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Estrogen and Progesterone Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Gedeon Richter Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 73. Gedeon Richter Estrogen and Progesterone Product Portfolios and Specifications
Table 74. Gedeon Richter Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Gedeon Richter Main Business
Table 76. Gedeon Richter Latest Developments
Table 77. Bayer Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 78. Bayer Estrogen and Progesterone Product Portfolios and Specifications
Table 79. Bayer Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Bayer Main Business
Table 81. Bayer Latest Developments
Table 82. N.V.Organon Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 83. N.V.Organon Estrogen and Progesterone Product Portfolios and Specifications
Table 84. N.V.Organon Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. N.V.Organon Main Business
Table 86. N.V.Organon Latest Developments
Table 87. Pfizer Healthcare Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 88. Pfizer Healthcare Estrogen and Progesterone Product Portfolios and Specifications
Table 89. Pfizer Healthcare Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Pfizer Healthcare Main Business
Table 91. Pfizer Healthcare Latest Developments
Table 92. Jenapharm Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 93. Jenapharm Estrogen and Progesterone Product Portfolios and Specifications
Table 94. Jenapharm Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. Jenapharm Main Business
Table 96. Jenapharm Latest Developments
Table 97. Besins Healthcare Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 98. Besins Healthcare Estrogen and Progesterone Product Portfolios and Specifications
Table 99. Besins Healthcare Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Besins Healthcare Main Business
Table 101. Besins Healthcare Latest Developments
Table 102. MERCK SERONO Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 103. MERCK SERONO Estrogen and Progesterone Product Portfolios and Specifications
Table 104. MERCK SERONO Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 105. MERCK SERONO Main Business
Table 106. MERCK SERONO Latest Developments
Table 107. Abbott Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 108. Abbott Estrogen and Progesterone Product Portfolios and Specifications
Table 109. Abbott Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 110. Abbott Main Business
Table 111. Abbott Latest Developments
Table 112. Teva Pharma Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Pharma Estrogen and Progesterone Product Portfolios and Specifications
Table 114. Teva Pharma Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 115. Teva Pharma Main Business
Table 116. Teva Pharma Latest Developments
Table 117. Aspen Pharmacare Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 118. Aspen Pharmacare Estrogen and Progesterone Product Portfolios and Specifications
Table 119. Aspen Pharmacare Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. Aspen Pharmacare Main Business
Table 121. Aspen Pharmacare Latest Developments
Table 122. Dr.Kade Pharmazeutische Fabrik Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 123. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Product Portfolios and Specifications
Table 124. Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 125. Dr.Kade Pharmazeutische Fabrik Main Business
Table 126. Dr.Kade Pharmazeutische Fabrik Latest Developments
Table 127. F.I.S.-FABBRICA Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 128. F.I.S.-FABBRICA Estrogen and Progesterone Product Portfolios and Specifications
Table 129. F.I.S.-FABBRICA Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 130. F.I.S.-FABBRICA Main Business
Table 131. F.I.S.-FABBRICA Latest Developments
Table 132. Eli Lilly Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 133. Eli Lilly Estrogen and Progesterone Product Portfolios and Specifications
Table 134. Eli Lilly Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 135. Eli Lilly Main Business
Table 136. Eli Lilly Latest Developments
Table 137. Orion Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 138. Orion Estrogen and Progesterone Product Portfolios and Specifications
Table 139. Orion Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 140. Orion Main Business
Table 141. Orion Latest Developments
Table 142. AstraZeneca Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 143. AstraZeneca Estrogen and Progesterone Product Portfolios and Specifications
Table 144. AstraZeneca Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 145. AstraZeneca Main Business
Table 146. AstraZeneca Latest Developments
Table 147. Novartis Pharma Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 148. Novartis Pharma Estrogen and Progesterone Product Portfolios and Specifications
Table 149. Novartis Pharma Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 150. Novartis Pharma Main Business
Table 151. Novartis Pharma Latest Developments
Table 152. Novo Nordisk Basic Information, Estrogen and Progesterone Manufacturing Base, Sales Area and Its Competitors
Table 153. Novo Nordisk Estrogen and Progesterone Product Portfolios and Specifications
Table 154. Novo Nordisk Estrogen and Progesterone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 155. Novo Nordisk Main Business
Table 156. Novo Nordisk Latest Developments


List of Figures
Figure 1. Picture of Estrogen and Progesterone
Figure 2. Estrogen and Progesterone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Estrogen and Progesterone Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Estrogen and Progesterone Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Estrogen and Progesterone Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Estrogen and Progesterone Sales Market Share by Country/Region (2024)
Figure 10. Estrogen and Progesterone Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Estrogen
Figure 12. Product Picture of Progesterone
Figure 13. Global Estrogen and Progesterone Sales Market Share by Type in 2025
Figure 14. Global Estrogen and Progesterone Revenue Market Share by Type (2020-2025)
Figure 15. Estrogen and Progesterone Consumed in Pharmacy
Figure 16. Global Estrogen and Progesterone Market: Pharmacy (2020-2025) & (K Pcs)
Figure 17. Estrogen and Progesterone Consumed in Hospital
Figure 18. Global Estrogen and Progesterone Market: Hospital (2020-2025) & (K Pcs)
Figure 19. Estrogen and Progesterone Consumed in Department of Endocrinology
Figure 20. Global Estrogen and Progesterone Market: Department of Endocrinology (2020-2025) & (K Pcs)
Figure 21. Global Estrogen and Progesterone Sale Market Share by Application (2024)
Figure 22. Global Estrogen and Progesterone Revenue Market Share by Application in 2025
Figure 23. Estrogen and Progesterone Sales by Company in 2025 (K Pcs)
Figure 24. Global Estrogen and Progesterone Sales Market Share by Company in 2025
Figure 25. Estrogen and Progesterone Revenue by Company in 2025 ($ millions)
Figure 26. Global Estrogen and Progesterone Revenue Market Share by Company in 2025
Figure 27. Global Estrogen and Progesterone Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Estrogen and Progesterone Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Estrogen and Progesterone Sales 2020-2025 (K Pcs)
Figure 30. Americas Estrogen and Progesterone Revenue 2020-2025 ($ millions)
Figure 31. APAC Estrogen and Progesterone Sales 2020-2025 (K Pcs)
Figure 32. APAC Estrogen and Progesterone Revenue 2020-2025 ($ millions)
Figure 33. Europe Estrogen and Progesterone Sales 2020-2025 (K Pcs)
Figure 34. Europe Estrogen and Progesterone Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Estrogen and Progesterone Sales 2020-2025 (K Pcs)
Figure 36. Middle East & Africa Estrogen and Progesterone Revenue 2020-2025 ($ millions)
Figure 37. Americas Estrogen and Progesterone Sales Market Share by Country in 2025
Figure 38. Americas Estrogen and Progesterone Revenue Market Share by Country (2020-2025)
Figure 39. Americas Estrogen and Progesterone Sales Market Share by Type (2020-2025)
Figure 40. Americas Estrogen and Progesterone Sales Market Share by Application (2020-2025)
Figure 41. United States Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Estrogen and Progesterone Sales Market Share by Region in 2025
Figure 46. APAC Estrogen and Progesterone Revenue Market Share by Region (2020-2025)
Figure 47. APAC Estrogen and Progesterone Sales Market Share by Type (2020-2025)
Figure 48. APAC Estrogen and Progesterone Sales Market Share by Application (2020-2025)
Figure 49. China Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 53. India Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Estrogen and Progesterone Sales Market Share by Country in 2025
Figure 57. Europe Estrogen and Progesterone Revenue Market Share by Country (2020-2025)
Figure 58. Europe Estrogen and Progesterone Sales Market Share by Type (2020-2025)
Figure 59. Europe Estrogen and Progesterone Sales Market Share by Application (2020-2025)
Figure 60. Germany Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 61. France Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Estrogen and Progesterone Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Estrogen and Progesterone Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Estrogen and Progesterone Sales Market Share by Application (2020-2025)
Figure 68. Egypt Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Estrogen and Progesterone Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Estrogen and Progesterone in 2025
Figure 74. Manufacturing Process Analysis of Estrogen and Progesterone
Figure 75. Industry Chain Structure of Estrogen and Progesterone
Figure 76. Channels of Distribution
Figure 77. Global Estrogen and Progesterone Sales Market Forecast by Region (2026-2031)
Figure 78. Global Estrogen and Progesterone Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Estrogen and Progesterone Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Estrogen and Progesterone Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Estrogen and Progesterone Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Estrogen and Progesterone Revenue Market Share Forecast by Application (2026-2031)